January 2025

CARDIOVASCULAR

OUTCOMES OF TRANSSEPTAL MITRAL VALVE-IN-VALVE IN PATIENTS WITH INTERMEDIATE SURGICAL RISK

Featuring: ​​​S. Chris Malaisrie, MD

Episode Summary

S. Chris Malaisrie, MD, cardiac surgeon, discusses the one-year outcomes of the PARTNER 3 Mitral Valve in Valve (MViV) clinical trial. The trial is investigating the safety and efficacy of transcatheter MViV for intermediate-risk patients who present with a failing mitral bioprosthetic valve.
S. Christopher Malaisrie, MD, ​cardiac surgeon, Professor of Surgery (Cardiac Surgery)

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​

You May Also Like